Contributing Authors |
|
iii | |
Preface |
|
vi | |
Clinical Manifestations |
|
|
|
|
|
|
|
|
|
|
|
|
|
1-1 | (1) |
|
|
1-3 | (1) |
|
|
1-5 | (1) |
|
|
1-8 | (1) |
|
|
1-11 | (1) |
|
|
1-16 | (1) |
|
|
1-20 | (1) |
|
|
1-21 | (1) |
|
|
1-22 | (1) |
|
Thrombotic Microangiopathy |
|
|
1-23 | (1) |
|
Acute Kidney Injury (AKI) |
|
|
1-24 | (1) |
|
Chronic Kidney Disease (CKD) |
|
|
1-29 | (1) |
|
Transition of Care for Young Adults |
|
|
1-33 | (1) |
Diagnosis |
|
|
|
|
|
|
|
|
|
|
2-1 | (1) |
|
|
2-2 | (1) |
|
|
2-8 | (1) |
|
|
2-10 | (1) |
|
|
2-12 | (1) |
|
|
2-17 | (1) |
Treatment And Toxin |
|
|
|
|
|
|
|
|
|
|
|
|
3-1 | (1) |
|
|
3-2 | (1) |
|
|
3-6 | (1) |
|
|
3-9 | (1) |
|
Nonsteroidal Anti-Inflammatory Drugs |
|
|
3-11 | (1) |
|
|
3-12 | (1) |
|
Immunosuppressive Therapy |
|
|
3-16 | (1) |
|
|
3-27 | (1) |
|
Illicit, Herbal, and Environmental Toxins |
|
|
3-30 | (1) |
|
|
3-33 | (1) |
|
Intoxication and Poisoning |
|
|
3-34 | (1) |
Electrolytes And Acid Base Balance |
|
|
|
|
|
|
4-1 | (1) |
|
Evaluation of Acid-Base Balance |
|
|
4-3 | (1) |
|
|
4-4 | (1) |
|
|
4-12 | (1) |
|
|
4-14 | (1) |
|
|
4-15 | (1) |
|
|
4-15 | (1) |
|
|
4-21 | (1) |
|
|
4-28 | (1) |
|
|
4-31 | (1) |
|
|
4-33 | (1) |
Tubular, Interstitial, And Cystic Diseases |
|
|
|
|
|
|
|
Acute Tubular Necrosis (ATN) |
|
|
5-1 | (1) |
|
|
5-2 | (1) |
|
|
5-3 | (1) |
|
|
5-6 | (1) |
|
|
5-8 | (1) |
|
Immunoglobulin G4-Related Disease |
|
|
5-10 | (1) |
|
|
5-11 | (1) |
|
Hereditary Cystic Diseases |
|
|
5-12 | (1) |
|
Renal Cell Carcinoma (RCC) |
|
|
5-15 | (1) |
Extrarenal Diseases |
|
|
|
Urinary Tract Obstruction (UTO) |
|
|
6-1 | (1) |
|
|
6-2 | (1) |
|
Urinary Tract Infection (UTI) |
|
|
6-3 | (1) |
Glomerular And Vascular Diseases |
|
|
|
|
|
|
|
|
|
Minimal Change Disease (MCD) |
|
|
7-1 | (1) |
|
Focal Segmental Glomerulosclerosis |
|
|
7-2 | (1) |
|
Membranous Nephropathy (MN) |
|
|
7-4 | (1) |
|
Pauci-Immune Glomerulonephritis |
|
|
7-7 | (1) |
|
|
7-10 | (1) |
|
Immunoglobulin A Nephropathy |
|
|
7-11 | (1) |
|
|
7-13 | (1) |
|
Infection-Related Glomerulonephritis |
|
|
7-15 | (1) |
|
Immune Complex-mediated MPGN |
|
|
7-17 | (1) |
|
|
7-18 | (1) |
|
|
7-20 | (1) |
|
|
7-21 | (1) |
|
Nonamyloid Deposition Diseases |
|
|
7-24 | (1) |
|
Hereditary Glomerular Diseases |
|
|
7-25 | (1) |
|
Antiphospholipid Syndrome (APS) |
|
|
7-27 | (1) |
|
|
7-28 | (1) |
|
|
7-29 | (1) |
Hypertension |
|
|
|
|
|
8-1 | (1) |
|
|
8-4 | (1) |
|
|
8-5 | (1) |
|
|
8-6 | (1) |
|
|
8-7 | (1) |
|
Obstructive Sleep Apnea (OSA) |
|
|
8-9 | (1) |
|
Renal Artery Stenosis (RAS) |
|
|
8-10 | (1) |
|
|
8-12 | (1) |
|
|
8-15 | (1) |
Specific Topics |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9-1 | (1) |
|
|
9-6 | (1) |
|
Extracorporeal Membrane Oxygenation |
|
|
9-9 | (1) |
|
|
9-10 | (1) |
|
|
9-13 | (1) |
|
|
9-16 | (1) |
|
|
9-17 | (1) |
|
|
9-19 | (1) |
|
|
9-24 | (1) |
|
Monoclonal Gammopathy (MG) |
|
|
9-25 | (1) |
|
Hematopoietic Stem Cell Transplantation |
|
|
9-28 | (1) |
|
|
9-29 | (1) |
|
|
9-34 | (1) |
|
Human Immunodeficiency Virus (HIV) |
|
|
9-37 | (1) |
|
|
9-39 | (1) |
|
|
9-42 | (1) |
|
|
9-43 | (1) |
|
CKD-Mineral and Bone Disorder |
|
|
9-44 | (1) |
|
|
9-45 | (1) |
|
Primary Hyperparathyroidism |
|
|
9-48 | (1) |
|
|
9-49 | (1) |
|
|
9-51 | (1) |
|
|
9-54 | (1) |
|
Psychiatry, Sleep Medicine, and Neurology |
|
|
9-56 | (1) |
|
|
9-61 | (1) |
|
|
9-66 | (1) |
|
|
9-68 | (1) |
|
|
9-70 | (1) |
|
Geriatrics Palliative Care 91 |
|
|
Renal Replacement Therapy |
|
|
|
|
|
|
|
|
|
10-1 | (1) |
|
|
10-3 | (1) |
|
|
10-4 | (1) |
|
Continuous Renal Replacement Therapy |
|
|
10-5 | (1) |
|
HD Initiation and Prescription |
|
|
10-8 | (1) |
|
|
10-11 | (1) |
|
|
10-13 | (1) |
|
|
10-14 | (1) |
|
|
10-19 | (1) |
|
|
10-26 | (1) |
|
|
10-27 | (1) |
|
|
10-30 | (1) |
|
|
10-31 | (1) |
|
|
10-33 | (1) |
Transplantation |
|
|
Vasanthi Balaramanjae Hyung Chang |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11-1 | (1) |
|
|
11-3 | (1) |
|
Immunologic Testing and Monitoring |
|
|
11-5 | (1) |
|
|
11-7 | (1) |
|
|
11-8 | (1) |
|
Acute Cellular Rejection (ACR) |
|
|
11-13 | (1) |
|
Antibody-mediated Rejection (AMR) |
|
|
11-14 | (1) |
|
|
11-16 | (1) |
|
Metabolic Complication after KT |
|
|
11-19 | (1) |
|
|
11-21 | (1) |
|
|
11-22 | (1) |
|
Renal Complication in Other Organ Transplantation |
|
|
11-24 | (1) |
Photo Insets |
|
|
|
|
|
P1-1 | |
|
|
P2-1 | |
Appendix Units And Molecular Weights |
|
12-1 | (1) |
Abbreviations |
|
13-1 | |
Index |
|
I-1 | |